Veldandi Uday Kiran - Novartis Healthcare Pvt Ltd

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 36 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Iptacopan in Idiopathic Immune Complex–Mediated Membranoproliferative Glomerulonephritis: Protocol of the APPARENT Multicenter, Randomized Phase 3 Study

Marina Vivarelli,Andrew S. Bomback,Matthias Meier,Yaqin Wang,Nicholas J. A. Webb,Uday Kiran Veldandi,Richard J. H. Smith,David Kavanagh

KIDNEY INTERNATIONAL REPORTSno. 1 (2024): 64-72

引用0浏览0WOS引用

BAYESIAN DYNAMIC BORROWING APPROACH FOR APPARENT PHASE 3 STUDY OF IPTACOPAN IN ICMPGN

Andrew Bomhack, David Kavanagh,Marina Vivarelli,Yaqin Wang,UdayKiran Veldandi,Nicholas Webb,Matthias Meier,Richard Smith

AMERICAN JOURNAL OF KIDNEY DISEASESno. 4 (2024): S124-S124

引用0浏览0引用

Wcn24-1146 safety and efficacy of iptacopan in adolescent patients with idiopathic (primary) immune-complex-mediated membranoproliferative glomerulonephritis (ic-mpgn)

Nicholas Webb,David Kavanagh,Andrew S. Bomback,Richard J.H. Smith,UdayKiran Veldandi,Yaqin Wang,Matthias Meier,Marina Vivarelli

Kidney International Reportsno. 4 (2024): S116-S117

引用0浏览0引用

42 APPARENT: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study to Assess the Efficacy and Safety of Iptacopan in Idiopathic (primary) Immune Complex-Mediated Membranoproliferative Glomerulonephritis

Nicholas Webb,Udaykiran Veldandi,David Kavanagh,Marina Vivarelli,Andrew Bomback,Yaqin Wang,Matthias Meier, Richard Smith

Immunobiology（2023）

引用0浏览0引用

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipients with Hepatocellular Carcinoma

Gonzalo Sapisochin,Wei Chen Lee, Dong Jin Joo,Jae-Won Joh, Koichiro Hata,Arvinder Singh Soin,Uday Kiran Veldandi,Shuhei Kaneko,Matthias Meier,Denise Leclair,Gangadhar Sunkara,Long Bin Jeng

Annals of Transplantation/Annals of transplantation (2022)

引用0浏览0WOS引用

Real-world Utilisation of the Rivastigmine Transdermal Patches Accompanying the Use of Risk Minimisation Tools in Patients with Dementia

Fritjof Reinhardt,Nikolaos Scarmeas,Rajesh Karan,Uday K. Veldandi, Sunil Modali, Krishna Duvvuri,Rashid K. Pathan

Current Alzheimer research（2021）

引用2浏览0WOS引用

Three-year Outcomes from the CRADLE Study in De Novo Pediatric Kidney Transplant Recipients Receiving Everolimus with Reduced Tacrolimus and Early Steroid Withdrawal

Burkhard Toenshoff,Helio Tedesco-Silva,Robert Ettenger,Martin Christian,Anna Bjerre,Luca Dello Strologo,Stephen D. Marks,Lars Pape,Udaykiran Veldandi,Patricia Lopez,Marc Cousin,Priti Pandey,Matthias Meier

American journal of transplantation（2021）

引用13浏览0WOS引用

Five Year Hepatocellular Carcinoma Recurrence With Everolimus Plus Reduced Tacrolimus Vs Standard Tacrolimus After Living-Donor Liver Transplantation

Gonzalo Sapisochin, Long Bin Jeng,Koichiro Hata,Wei Chen Lee,Jae-Won Joh, Dong Jin Joo,Arvinder Singh Soin,Uday Kiran Veldandi,Shuhei Kaneko, Kanan Jhala,Matthias Meier,Denise Leclair,Gangadhar Sunkara

TRANSPLANT INTERNATIONAL（2021）

引用0浏览0引用

COMPARISON OF THE EFFICACY AND SAFETY OF EVEROLIMUS REGIMEN BETWEEN ASIAN AND NON-ASIAN LIVER TRANSPLANT RECIPIENTS

Uday Kiran Veldandi, Susan Gu,Venugopal Marasanapalle,Shuhei Kaneko,Priti Pandey,Bledar Haderi,Gangadhar Sunkara

HEPATOLOGY (2021): 875A-876A

引用0浏览0引用

CRADLE STUDY: THREE-YEAR RESULTS OF GROWTH AND SEXUAL MATURATION IN PEDIATRIC KIDNEY TRANSPLANT PATIENTS RECEIVING EVEROLIMUS WITH REDUCED TACROLIMUS AND EARLY STEROID WITHDRAWAL

H. Billing,L. Pape,M. Kemper, J. Oh, M. Konrad,U. Veldandi,M. Meier,K. Hessel,B. Toenshoff

TRANSPLANT INTERNATIONAL（2019）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn